Search
China Biopharmaceutical: Pioneering Out-licensing Deal on the Horizon
3 day ago /
Read about 0 minute
Author：小编
At the 2025 ASCO Annual Meeting, China Biopharmaceutical showcased groundbreaking data for an impressive twelve innovative products, establishing a new benchmark for Chinese pharmaceutical firms. Concurrently, the company has made out-licensing a cornerstone of its strategic plan, with a pioneering deal anticipated to be finalized in the near future.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
